共 50 条
- [1] Comprehensive Assessment of Targetable Driver Alterations in Lung Adenocarcinomas Using a Clinical, Hybrid Capture-Based, Next-Generation Sequencing AssayMODERN PATHOLOGY, 2015, 28 : 511A - 511AArcila, MariaZehir, AhmetCheng, DonavanYu, HelenaKris, MarcDrilon, AlexanderRiely, GregoryBoger, MichaelLadanyi, Marc
- [2] Comprehensive Assessment of Targetable Somatic Alterations in Cytologic Cell Block Material Using a Clinical, Hybrid Capture-Based, Next-Generation Sequencing AssayLABORATORY INVESTIGATION, 2015, 95 : 524A - 524ASadowska, JustynaZehir, AhmetBenayed, RymaLadanyi, MarcLin, OscarArcila, Maria
- [3] Comprehensive Assessment of Targetable Somatic Alterations in Cytologic Cell Block Material Using a Clinical, Hybrid Capture-Based, Next-Generation Sequencing AssayMODERN PATHOLOGY, 2015, 28 : 524A - 524ASadowska, JustynaZehir, AhmetBenayed, RymaLadanyi, MarcLin, OscarArcila, Maria
- [4] Comprehensive assessment of targetable alterations in lung adenocarcinoma samples with limited material using MSK-IMPACT, a clinical, hybrid capture-based, next-generation sequencing (NGS) assayJOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)Arcila, Maria E.Yu, Helena AlexandraDrilon, Alexander E.Riely, Gregory J.Zehir, AhmetSadowska, JustynaHyman, David MichaelKris, Mark G.Berger, Michael F.Ladanyi, Marc
- [5] Comprehensive Assessment of RAS/RAF Mutation Status and Identification of Alternative Targetable Driver Alterations in RAS/RAF Wild Type Colorectal Carcinoma Using a Hybrid Capture-Based Next-Generation Sequencing AssayMODERN PATHOLOGY, 2015, 28 : 458A - 458AHechtman, JaclynZehir, AhmetCheng, DonavanShia, JinruSolit, DavidYaeger, RonaHyman, DavidArcila, MariaBerger, MichaelLadanyi, MarcVakiani, Efsevia
- [6] Comprehensive Assessment of RAS/RAF Mutation Status and Identification of Alternative Targetable Driver Alterations in RAS/RAF Wild Type Colorectal Carcinoma Using a Hybrid Capture-Based Next-Generation Sequencing AssayLABORATORY INVESTIGATION, 2015, 95 : 458A - 458AHechtman, JaclynZehir, AhmetCheng, DonavanShia, JinriSolit, DavidYaeger, RonaHyman, DavidArcila, MariaBerger, MichaelLadanyi, MarcVakiani, Efsevia
- [7] Clinically Adoption of MSK-IMPACT, a Hybridization Capture-Based next Generation Sequencing Assay, for the Assessment of Lung AdenocarcinomasJOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S341 - S342Arcila, Maria E.Zehir, AhmetYu, HelenaDrilon, AlexanderLi, Bob T.Riely, Gregory J.Rekhtman, NatashaLin, OscarHyman, DavidBerger, MichaelRudin, Charles M.Kris, Mark G.Ladanyi, Marc
- [8] Identification of novel and potentially targetable receptor tyrosine kinase alterations in colorectal carcinoma using a 341 gene hybrid capture-based next-generation sequencing assay.JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)Hechtman, Jaclyn FrancesArcila, Maria E.Cheng, Donavan T.Solit, David B.Yaeger, Rona D.Hyman, David MichaelBerger, Michael F.Shia, JinruVakiani, EfseviaZehir, AhmetLadanyi, Marc
- [9] Clinical Impact of Hybrid Capture-Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung CancerJOURNAL OF THORACIC ONCOLOGY, 2017, 12 (02) : 258 - 268Rozenblum, Anna BelilovskiIlouze, MayaDudnik, ElizabethDvir, AddieSoussan-Gutman, LiorGeva, SmadarPeled, Nir
- [10] Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing ApproachesCLINICAL CANCER RESEARCH, 2015, 21 (16) : 3631 - 3639Drilon, AlexanderWang, LuArcila, Maria E.Balasubramanian, SohailGreenbowe, Joel R.Ross, Jeffrey S.Stephens, PhilLipson, DoronMiller, Vincent A.Kris, Mark G.Ladanyi, MarcRizvi, Naiyer A.